Human antibody–Fc receptor interactions illuminated by crystal structures

Immunoglobulins couple the recognition of invading pathogens with the triggering of potent effector mechanisms for pathogen elimination. Different immunoglobulin classes trigger different effector mechanisms through interaction of immunoglobulin Fc regions with specific Fc receptors (FcRs) on immune cells. Here, we review the structural information that is emerging on three human immunoglobulin classes and their FcRs. New insights are provided, including an understanding of the antibody conformational adjustments that are required to bring effector cell and target cell membranes sufficiently close for efficient killing and signal transduction to occur. The results might also open up new possibilities for the design of therapeutic antibodies.

[1]  M. Eibl,et al.  Physical and Functional Association of FcαR With Protein Tyrosine Kinase Lyn , 1998 .

[2]  B. Baird,et al.  Dynamic conformations compared for IgE and IgG1 in solution and bound to receptors. , 1992, Biochemistry.

[3]  J. V. D. van de Winkel,et al.  Human antibodies as next generation therapeutics. , 2001, Current opinion in chemical biology.

[4]  C. Sautès-Fridman,et al.  The Structure of a Human Type III Fcγ Receptor in Complex with Fc* , 2001, The Journal of Biological Chemistry.

[5]  Garrett M. Morris,et al.  Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design , 2001, Science.

[6]  G J Kleywegt,et al.  Crystal structure of the C2 fragment of streptococcal protein G in complex with the Fc domain of human IgG. , 1995, Structure.

[7]  A G Brooks,et al.  Crystal structure of the extracellular domain of a human Fc gamma RIII. , 2000, Immunity.

[8]  Wei Zhang,et al.  Crystal Structure of the Ectodomain of Human FcαRI* , 2003, Journal of Biological Chemistry.

[9]  R. Parkhouse,et al.  Electron microscopy of human and mouse myeloma serum IgA. , 1971, Journal of molecular biology.

[10]  F. Denizot,et al.  A new member of the immunoglobulin superfamily—CTLA-4 , 1987, Nature.

[11]  M. Hulett,et al.  Identification of residues in the first domain of human Fc alpha receptor essential for interaction with IgA. , 1999, Journal of immunology.

[12]  D. Burton,et al.  Human Fc gamma RI and Fc gamma RII interact with distinct but overlapping sites on human IgG. , 1991, Journal of immunology.

[13]  J. Kinet,et al.  Crystal Structure of the Human High-Affinity IgE Receptor , 1998, Cell.

[14]  J. Dunlop,et al.  Identification of Residues in the CH2/CH3 Domain Interface of IgA Essential for Interaction with the Human Fcα Receptor (FcαR) CD89* , 1999, The Journal of Biological Chemistry.

[15]  M. Kerr,et al.  The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling. , 1999, Journal of molecular biology.

[16]  D. Holdstock.  Past, present--and future? , 2005, Medicine, conflict, and survival.

[17]  K. Shitara,et al.  The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular Cytotoxicity* , 2003, The Journal of Biological Chemistry.

[18]  Clinton L White,et al.  Bivalent binding of IgA1 to FcalphaRI suggests a mechanism for cytokine activation of IgA phagocytosis. , 2003, Journal of molecular biology.

[19]  G. Sutherland,et al.  The gene for the human IgA Fc receptor maps to 19q13.4 , 1992, Human Genetics.

[20]  J. Kinet,et al.  A Conformational Rearrangement upon Binding of IgE to Its High Affinity Receptor* , 1996, The Journal of Biological Chemistry.

[21]  T. Waldmann,et al.  Immunotherapy: past, present and future , 2003, Nature Medicine.

[22]  E. Witort,et al.  Identification of the IgG binding site of the human low affinity receptor for IgG Fc gamma RII. Enhancement and ablation of binding by site-directed mutagenesis. , 1994, The Journal of biological chemistry.

[23]  L J Harris,et al.  Crystallographic structure of an intact IgG1 monoclonal antibody. , 1998, Journal of molecular biology.

[24]  D. Davies,et al.  Three-dimensional structure of an intact human immunoglobulin. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Rivera.  Molecular adapters in FcεRI signaling and the allergic response , 2002 .

[26]  T. Jardetzky,et al.  Structure of the Human IgE-Fc Cε3-Cε4 Reveals Conformational Flexibility in the Antibody Effector Domains , 2000 .

[27]  K. Kwiatkowska,et al.  The clustered Fcγ  receptor II is recruited to Lyn‐containing membrane domains and undergoes phosphorylation in a cholesterol‐dependent manner , 2001, European journal of immunology.

[28]  W. Delano,et al.  Convergent solutions to binding at a protein-protein interface. , 2000, Science.

[29]  D. Burton,et al.  A model for the solution conformation of rat IgE. , 1990, Biochemical Society transactions.

[30]  J. Woof,et al.  Limited role of charge matching in the interaction of human immunoglobulin A with the immunoglobulin A Fc receptor (FcαRI) CD89 , 2003, Immunology.

[31]  J. Kinet,et al.  Structure of the Fc fragment of human IgE bound to its high-affinity receptor FcεRIα , 2000, Nature.

[32]  D. Burton,et al.  Localisation of the monocyte-binding region on human immunoglobulin G. , 1986, Molecular immunology.

[33]  A. Edmundson,et al.  Three-dimensional structure of a human immunoglobulin with a hinge deletion. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[34]  S. Svehag,et al.  FURTHER STUDIES ON THE ULTRASTRUCTURE OF DIMERIC IGA OF HUMAN ORIGIN , 1971, The Journal of experimental medicine.

[35]  K. Roux,et al.  Comparisons of the ability of human IgG3 hinge mutants, IgM, IgE, and IgA2, to form small immune complexes: a role for flexibility and geometry. , 1998, Journal of immunology.

[36]  Robyn L Stanfield,et al.  Contrasting IgG structures reveal extreme asymmetry and flexibility. , 2002, Journal of molecular biology.

[37]  D. Burton.  Is IgM-like dislocation a common feature of antibody function? , 1986, Immunology today.

[38]  J. Leusen,et al.  Mac-1 (CD11b/CD18) as Accessory Molecule for FcαR (CD89) Binding of IgA1 , 2002, The Journal of Immunology.

[39]  P. Sun,et al.  Recognition of immunoglobulins by Fcγ receptors , 2002 .

[40]  T. Mayadas,et al.  Human Immunoglobulin A Receptor (FcRI, CD89) Function in Transgenic Mice Requires Both FcR γ Chain and CR3 (CD11b/CD18) , 1999 .

[41]  D. Burton,et al.  Human antibody effector function. , 1992, Advances in immunology.

[42]  R. Dwek,et al.  The Glycosylation and Structure of Human Serum IgA1, Fab, and Fc Regions and the Role of N-Glycosylation on Fcα Receptor Interactions* , 1998, The Journal of Biological Chemistry.

[43]  R. Monteiro,et al.  IgA Fc receptors. , 2003, Annual review of immunology.

[44]  Eric O Long,et al.  Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors , 1997, Nature.

[45]  L. Presta,et al.  Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity* , 2002, The Journal of Biological Chemistry.

[46]  M. Colonna,et al.  Organization of the leukocyte receptor cluster (LRC) on human Chromosome 19q13.4 , 1999, Mammalian Genome.

[47]  D. Burton,et al.  Interaction of human IgG chimeric antibodies with the human FcRI and FcRII receptors: requirements for antibody-mediated host cell-target cell interaction. , 1989, Molecular immunology.

[48]  B. Baird,et al.  FcϵRI as a paradigm for a lipid raft-dependent receptor in hematopoietic cells , 2001 .

[49]  P. Artymiuk,et al.  The Immunoglobulin Receptors and their Physiological and Pathological Roles in Immunity , 1998, Immunology and Medicine Series.

[50]  H. Metzger,et al.  Dimeric immunoglobulin E serves as a unit signal for mast cell degranulation. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[51]  David Cowburn,et al.  The structure of the IgE Cɛ2 domain and its role in stabilizing the complex with its high-affinity receptor FcɛRIα , 2001, Nature Structural Biology.

[52]  J. Salmon,et al.  Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease. , 2001, Arthritis and rheumatism.

[53]  Alexander McPherson,et al.  The three-dimensional structure of an intact monoclonal antibody for canine lymphoma , 1992, Nature.

[54]  B. Stadler,et al.  Interaction of Human IgE with Fc Epsilon RI Alpha Exposes Hidden Epitopes on IgE , 1999, International Archives of Allergy and Immunology.

[55]  B. Baird,et al.  Compartmentalized Activation of the High Affinity Immunoglobulin E Receptor within Membrane Domains* , 1997, The Journal of Biological Chemistry.

[56]  H. Petty,et al.  Interactions of integrins with their partner proteins in leukocyte membranes , 2002, Immunologic research.

[57]  M. Taussig,et al.  Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody—antigen interaction , 1997, Nature Structural Biology.

[58]  W. Wade,et al.  γ-Chain Dependent Recruitment of Tyrosine Kinases to Membrane Rafts by the Human IgA Receptor FcαR , 1999, The Journal of Immunology.

[59]  B. Corthésy.  Recombinant immunoglobulin A: powerful tools for fundamental and applied research. , 2002, Trends in biotechnology.

[60]  D. Burton.  Immunoglobulin G: functional sites. , 1985, Molecular immunology.

[61]  J. Kinet,et al.  The analysis of the human high affinity IgE receptor Fc epsilon Ri alpha from multiple crystal forms. , 2001, Journal of molecular biology.

[62]  C. van Kooten,et al.  Immunoglobulin-binding Sites of Human FcαRI (CD89) and Bovine Fcγ2R Are Located in their Membrane-distal Extracellular Domains , 1999, The Journal of experimental medicine.

[63]  J. Kinet,et al.  The analysis of the human high affinity IgE receptor FcεRIα from multiple crystal forms11Edited by I. A. Wilson , 2001 .

[64]  T. Katada,et al.  Association of FcγRII with Low-Density Detergent-Resistant Membranes Is Important for Cross-Linking-Dependent Initiation of the Tyrosine Phosphorylation Pathway and Superoxide Generation1 , 2001, The Journal of Immunology.

[65]  P. Barton,et al.  Crystal structure of the human leukocyte Fc receptor, FcγRIIa. , 1999, Nature Structural Biology.

[66]  T. Wade,et al.  IgA Fc receptor (FcalphaR) cross-linking recruits tyrosine kinases, phosphoinositide kinases and serine/threonine kinases to glycolipid rafts. , 2002, The Biochemical journal.

[67]  J. Bolen,et al.  Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases , 1992, Nature.

[68]  E. Witort,et al.  Multiple Regions of Human FcγRII (CD32) Contribute to the Binding of IgG (*) , 1995, The Journal of Biological Chemistry.

[69]  Henry Metzger,et al.  Molecular versatility of antibodies , 2002, Immunological reviews.

[70]  Robert Huber,et al.  The 3.2-Å crystal structure of the human IgG1 Fc fragment–FcγRIII complex , 2000, Nature.

[71]  R. Owens,et al.  The crystal structure of IgE Fc reveals an asymmetrically bent conformation , 2002, Nature Immunology.

[72]  Inger Sandlie,et al.  Therapeutic antibodies for human diseases at the dawn of the twenty-first century , 2003, Nature Reviews Drug Discovery.

[73]  Sayers,et al.  The structural basis of human IgE–Fc receptor interactions , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[74]  R. Huber,et al.  Crystallographic structure studies of an IgG molecule and an Fc fragment , 1976, Nature.

[75]  J. Deisenhofer.  Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution. , 1981, Biochemistry.

[76]  U. Jacob,et al.  Crystal structure of the soluble form of the human Fcγ‐receptor IIb: a new member of the immunoglobulin superfamily at 1.7 Å resolution , 1999, The EMBO journal.

[77]  D. Burton,et al.  Localization of the binding site for the human high-affinity Fc receptor on IgG , 1988, Nature.

[78]  J. Ravetch.  Fc receptors. , 1997, Current opinion in immunology.

[79]  A. Feinstein,et al.  Electron Microscope Examination of Free IgA Molecules and of their Complexes with Antigen , 1971, Nature.

[80]  M. Kerr,et al.  The specificity of the human neutrophil IgA receptor (Fc alpha R) determined by measurement of chemiluminescence induced by serum or secretory IgA1 or IgA2. , 1990, Immunology.

[81]  M. Reth.  Antigen receptor tail clue , 1989, Nature.

[82]  A. Kister,et al.  The IgG Binding Site of Human FcRIIIB Receptor Involves CC′ and FG Loops of the Membrane-proximal Domain (*) , 1996, The Journal of Biological Chemistry.

[83]  Marjolein van Egmond,et al.  FcαRI-positive liver Kupffer cells: Reappraisal of the function of immunoglobulin A in immunity , 2000, Nature Medicine.

[84]  U. Jacob,et al.  Molecular basis for immune complex recognition: a comparison of Fc-receptor structures. , 2001, Journal of molecular biology.

[85]  M. Hulett,et al.  The second and third extracellular domains of FcgammaRI (CD64) confer the unique high affinity binding of IgG2a. , 1998, Molecular immunology.

[86]  L. Presta.  Engineering antibodies for therapy. , 2002, Current pharmaceutical biotechnology.

[87]  P. Bjorkman,et al.  Insights into IgA-mediated immune responses from the crystal structures of human FcαRI and its complex with IgA1-Fc , 2003, Nature.

[88]  B. Baird,et al.  Conformations of IgE bound to its receptor Fc epsilon RI and in solution. , 1991, Biochemistry.

[89]  S. Morrison,et al.  The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region , 1991, The Journal of experimental medicine.

[90]  M. Hulett,et al.  Fine Structure Analysis of Interaction of FcεRI with IgE* , 1999, The Journal of Biological Chemistry.

[91]  A. West,et al.  Crystal structure at 2.8 A of an FcRn/heterodimeric Fc complex: mechanism of pH-dependent binding. , 2001, Molecular cell.

[92]  G. Lindahl,et al.  Streptococcal IgA-binding Proteins Bind in the Cα2-Cα3 Interdomain Region and Inhibit Binding of IgA to Human CD89* , 2001, The Journal of Biological Chemistry.

[93]  A. West,et al.  Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2). , 2000, Immunity.

[94]  Janice M Reichert,et al.  Therapeutic monoclonal antibodies: trends in development and approval in the US. , 2002, Current opinion in molecular therapeutics.

[95]  L. Carayannopoulos,et al.  Localization of the binding site for the monocyte immunoglobulin (Ig) A- Fc receptor (CD89) to the domain boundary between Calpha2 and Calpha3 in human IgA1 , 1996, The Journal of experimental medicine.

[96]  D. Burton.  Antibody: the flexible adaptor molecule. , 1990, Trends in biochemical sciences.

[97]  M. Klein,et al.  Identification of the Fc gamma receptor class I binding site in human IgG through the use of recombinant IgG1/IgG2 hybrid and point-mutated antibodies. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[98]  C. Lay,et al.  The Interaction of FcαRI with IgA and Its Implications for Ligand Binding by Immunoreceptors of the Leukocyte Receptor Cluster1 , 2001, The Journal of Immunology.

[99]  R. Huber,et al.  Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. , 2003, Journal of molecular biology.